Multivariable competing risks regression analysis | |||
---|---|---|---|
SHR | 95%CI | p value | |
Age | |||
<70 | Ref | ||
≥ 70 | 1.456 | 1.249–1.698 | <0.001* |
Grade | |||
I/ II | Ref | ||
III /IV | 1.116 | 0.939–1.327 | 0.213 |
Histology | |||
SCC/TCC/AC | Ref | ||
Other | 1.008 | 0.795–1.276 | 0.950 |
T stage | |||
T0/T1/T2 | Ref | ||
T3/T4 | 1.076 | 0.811–1.427 | 0.613 |
N stage | |||
N0 | Ref | ||
N1/N2 | 1.264 | 0.997–1.603 | 0.053 |
M stage | |||
M0 | Ref | ||
M1 | 2.556 | 1.986–3.290 | <0.001* |
AJCC stage groups | |||
I/ II | Ref | ||
III /IV | 1.469 | 1.059–2.039 | 0.021* |
Tumor size, mm | |||
<30 | Ref | ||
≥ 30 | 1.311 | 1.095–1.568 | 0.003* |
Surgery | |||
No surgery | Ref | ||
Local/Radical therapy | 0.760 | 0.636–0.908 | 0.003* |